Polyphenols from green tea and pomegranate for prevention of prostate cancer (Q36610398)

15 August 2017

1 reference

title

Polyphenols from green tea and pomegranate for prevention of prostate cancer (English)

1 reference

15 August 2017

1 reference

1 reference

Vaqar M Adhami

1

1 reference

PubMed ID

17015254

15 August 2017

Hasan Mukhtar

series ordinal

2

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

Free Radical Research

1 reference

15 August 2017

40

1 reference

15 August 2017

1095-1104

1 reference

15 August 2017

10

1 reference

15 August 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Cancer chemoprevention: scientific promise, clinical uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Antioxidants of the beverage tea in promotion of human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Tea beverage in chemoprevention of prostate cancer: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Green tea in chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Beneficial effects of tea and its polyphenols against prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Chemoprevention of prostate cancer: concepts and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Impact of diet on prostate cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Changing demography of prostate cancer in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Prostate cancer prevention through pomegranate fruit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Inhibition of lung tumorigenesis by tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Chemopreventive effects of green tea components on hepatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Estrogen Use and Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Ubiquitin, proteasomes, and the regulation of intracellular protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Proteasome inhibitors as potential novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Linking protein kinase C to cell-cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Epidemiology of prostate cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Diet and its preventive role in prostatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Black tea consumption and cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

The pomegranate: nature's power fruit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

Cancer chemoprevention: future holds in multiple agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760600796498

10.1080/10715760600796498

21 January 2018

Identifiers

DOI

1 reference

release_rqk4mr5a4ze6dpdfkuz2ryouve

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rqk4mr5a4ze6dpdfkuz2ryouve

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17015254

1 reference

PubMed ID

17015254